An Exploratory Study on the Efficacy and Safety of Abatacept in the Treatment of Refractory Dermatomyositis
Condition(s):Dermatomyositis; AbataceptLast Updated:July 1, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Dermatomyositis; AbataceptLast Updated:July 1, 2021Unknown status
Condition(s):DermatomyositisLast Updated:November 6, 2020Completed
Condition(s):Dermatomyositis; PolymyositisLast Updated:September 1, 2017Completed
Condition(s):DermatomyositisLast Updated:March 7, 2024Not yet recruiting
Condition(s):DermatomyositisLast Updated:December 5, 2022Enrolling by invitation
Condition(s):Lupus Erythematosus, SystemicLast Updated:March 18, 2024Recruiting
Condition(s):SLE (Systemic Lupus); Sjogren’s Syndrome; Systemic Scleroderma; Dermatomyositis; Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisLast Updated:September 28, 2023Recruiting
Condition(s):Dermatomyositis, Adult TypeLast Updated:March 3, 2023Completed
Condition(s):Dermatomyositis; Juvenile DermatomyositisLast Updated:September 16, 2021Completed
Condition(s):Polymyositis; DermatomyositisLast Updated:November 18, 2023Enrolling by invitation
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.